Cargando…
Increased risk of death associated with the use of proton‐pump inhibitors in patients with dementia and controls – a pharmacoepidemiological claims data analysis
BACKGROUND AND PURPOSE: The use of proton‐pump inhibitors (PPIs) was reported to be associated with increased mortality risk and has been proposed as a potential risk factor for neurodegenerative diseases. We aimed to assess the impact of PPI use on survival in patients with dementia as compared wit...
Autores principales: | Cetin, H., Wurm, R., Reichardt, B., Tomschik, M., Silvaieh, S., Parvizi, T., König, T., Erber, A., Schernhammer, E., Stamm, T., Stögmann, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496707/ https://www.ncbi.nlm.nih.gov/pubmed/32281706 http://dx.doi.org/10.1111/ene.14252 |
Ejemplares similares
-
Prescription patterns of antidementives in a high income country: A pharmacoepidemiologic study
por: Wurm, Raphael, et al.
Publicado: (2020) -
Co‐incidental C9orf72 expansion mutation‐related frontotemporal lobar degeneration pathology and sporadic Creutzfeldt−Jakob disease
por: Klotz, Sigrid, et al.
Publicado: (2020) -
Validity of the Brief Assessment of Impaired Cognition case‐finding instrument for identification of dementia subgroups and staging of dementia
por: Jørgensen, Kasper, et al.
Publicado: (2022) -
A European Academy of Neurology guideline on medical management issues in dementia
por: Frederiksen, K. S., et al.
Publicado: (2020) -
Dementia among international migrants: An urgent call for better care
por: Chen, Yaohua, et al.
Publicado: (2022)